The 'antisera' is yet to undergo human clinical trials to establish safety and efficacy
Smaller players are bullish on playing crucial role in nation's vaccine infrastructure
Union Health Minister Harsh Vardhan clarified on Sunday that the government is yet to take a final decision on phase-3 trials of the Russian COVID-19 vaccine candidate Sputnik V.
French biz confidence up despite resurgence, China eases entry rules for some foreigners, tough times for airlines as attempts to reopen falter, and other pandemic-related news across the globe
Firm also ties up with Washington University's school of medicine for intransal vaccine for Covid-19
It said people with a history or laboratory evidence of prior novel coronavirus infection should be allowed to participate in trials if they did not have acute COVID-19 or other acute infectious illne
The U.S. company's vaccine is in mid-stage trials after an early-stage trial showed it produced high levels of antibodies against the novel coronavirus
The results showed protective efficacacy, increasing Sars-CoV-2 specific IgG and neutralising antibodies reducing the replication of the virus in the nasal cavity, throat and lung tissues of monkey
Dmitriev told Sputnik that the clinical trials in Saudi Arabia, United Arab Emirates (UAE), the Philippines, India and Brazil will begin this month
Tripura's open-air classes, how to avoid super-spreaders, and what sero surveys hide--a roundup of news on how the country is dealing with the pandemic
A vaccine's ability to forestall a disease is also how vaccine developers typically design - and how regulators typically evaluate - Phase 3 clinical trials for vaccine candidates
Drug firm Zydus Cadila said it has received approval from Mexico's regulatory authority Cofepris to conduct clinical trials with its biological therapy "Pegylated Interferon alpha-2b"
The company, which had initially released the data from the trial in April, said the finding requires confirmation in clinical trials
Zydus Cadila has already successfully completed preclinical phase for its plasmid DNA vaccine candidate ZyCoV-D developed indigenously at its Vaccine Technology Centre in Ahmedabad
ICMR has developed the indigenous Covid-19 vaccine (BBV152 COVID vaccine) partnered with Bharat Biotech International Limited (BBIL)
The potential vaccine has received a certificate from the National Medical Products Administration to launch clinical trials
Clinical trials will begin next week
This is the first phytopharmaceutical drug (plant based) that the country's drug regulator has approved for clinical trials for Covid-19.
Several teams across the world are in a race to develop a vaccine for coronavirus infection
Local pharma units have already started work on developing patented drugs, some have already approached regulator for approvals